Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka® and Lotrel® on Albuminuria in Hypertensive, Type 2 Diabetic Subjects With Diabetic Nephropathy

NCT00234871 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00234871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka® and Lotrel® on Albuminuria in Hypertensive, Type 2 Diabetic Subjects With Diabetic Nephropathy
Lead sponsor
Abbott
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
Not reported
Enrollment
357 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hypertension, proteinuria